NTRK Fusion Gene Positive Advanced Solid Tumor Market Trends, Opportunities & Competitive Landscape
The NTRK Fusion Gene Positive Advanced Solid Tumor Market is developing across major oncology markets, with North America maintaining a leading position. The report estimates North America's market at USD 1.2 billion in 2024 and projects it to reach USD 3.5 billion by 2035. North America's leadership is supported by advanced healthcare infrastructure, substantial oncology research investment,...
0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр
Comunidad EDUCA https://comunidadeduca.com